AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DOCETAXEL 20 Mg ;

9 registrations across 1 African market— 9 active

Markets with DOCETAXEL 20 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Docetaxel Kabi 20mg/1ml
CONCENTRATE SOLUTION FOR INFUSION
🇪🇬EgyptFRESENIUS KABI-SCIENTIFIC OFFICEactive
Docetaxel Kabi 80mg/4ml
CONCENTRATE SOLUTION FOR INFUSION
🇪🇬EgyptFRESENIUS KABI-SCIENTIFIC OFFICEactive
Docetaxel Kabi 120mg/6ml
Concentrate For Solution For I.V Infusion
🇪🇬EgyptFRESENIUS KABI-SCIENTIFIC OFFICEactive
Docetaxel Kabi 20mg/1ml
CONCENTRATE SOLUTION FOR INFUSION
🇪🇬EgyptFRESENIUS KABI-SCIENTIFIC OFFICEactive
Docetaxel Kabi 80mg/4ml
CONCENTRATE SOLUTION FOR INFUSION
🇪🇬EgyptFRESENIUS KABI-SCIENTIFIC OFFICEactive
Bendadocel 20mg/1ml
Concentrate For Solution For I.V Infusion
🇪🇬EgyptPharmacon for Importationactive
Docetaxel Kabi 120mg/6ml
Concentrate For Solution For I.V Infusion
🇪🇬EgyptFRESENIUS KABI-SCIENTIFIC OFFICEactive
Bendadocel 20mg/1ml
Concentrate For Solution For I.V Infusion
🇪🇬EgyptPharmacon for Importationactive
Docetaxel 20 mg /1 ml
Concentrate for solution for Infusion
🇪🇬EgyptAl Esraa pharma for importactive

DOCETAXEL 20 Mg ; in Africa — Regulatory Overview

DOCETAXEL 20 Mg ; is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.